BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng R, Bu Y, Li F, Wu H, Wang Y, Wei W. The interplay between fibroblast-like synovial and vascular endothelial cells leads to angiogenesis via the sphingosine-1-phosphate-induced RhoA-F-Actin and Ras-Erk1/2 pathways and the intervention of geniposide. Phytother Res 2021. [PMID: 34327764 DOI: 10.1002/ptr.7211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng R, Wang Y, Bu Y, Wu H. Geniposide Augments Apoptosis in Fibroblast-like Synoviocytes by restoring Hypoxia-enhanced JNK-BNIP3-mediated Autophagy.. [DOI: 10.21203/rs.3.rs-2278733/v1] [Reference Citation Analysis]
2 Bu Y, Wu H, Deng R, Wang Y. Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation. Int Immunopharmacol 2022;111:109087. [PMID: 35908504 DOI: 10.1016/j.intimp.2022.109087] [Reference Citation Analysis]
3 Deng R, Wang Y, Bu Y, Wu H. BNIP3 mediates the different adaptive responses of fibroblast-like synovial cells to hypoxia in patients with osteoarthritis and rheumatoid arthritis. Mol Med 2022;28:64. [PMID: 35690741 DOI: 10.1186/s10020-022-00490-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang Y, Wu H, Gui B, Liu J, Rong G, Deng R, Bu Y, Zhang H. Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation. Phytomedicine 2022;100:154068. [DOI: 10.1016/j.phymed.2022.154068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bu Y, Wu H, Deng R, Wang Y. The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN. Inflammopharmacology 2022. [PMID: 35389123 DOI: 10.1007/s10787-022-00975-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]